Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths News Regulatory News (SNWS)

Share Price Information for Smiths News (SNWS)

Share Price is delayed by 15 minutes
Get Live Data
63.80    0.40 (0.63%)
Bid:
64.00
Ask:
65.00
Spread: 1.00 (1.563%)
Market Cap: £154.42m
SNWS Live PriceLast checked at - London Stock Exchange

Intraday Smiths News Share Chart

Contract Renewals - Frontline Seymour

17 Oct 2022 07:00

RNS Number : 0193D Smiths News PLC 17 October 2022 160

This announcement contains insie information

160

Smiths News PLC

("Smiths News")

160

Contract Renewals with Frontline Limite an Seymour Distribution Lt

160

Smiths News is please to announce that it has successfully secure two key long-term contracts, representing the first of the next publisher an istributor contract roun renewals for 202 onwars.160

The new agreements reache with Frontline (the UK's largest magazine istributor) an Seymour (part of the Frontline Group an the UK's largest inepenent magazine istributor) secure all of Smiths News' current istribution territories in the UK from 202 through to 2030 with Frontline an Seymour, representing revenues of c.163180m p.a. at current market values. 160Combine,160 the Frontline an Seymour portfolios account for over 0% of the UK magazine market an inclue titles such as 'Raio Times', 'Take A Break' an 'TV Choice'.

The new contracts are an enorsement of the future of the printe magazine category an confirm Smiths News' leaing position as the UK's foremost route to market for publishers. The contracts provie a founation to continue other publisher contract iscussions, which are unerway.

Jon Bunting, Chief Executive Officer, commente:

"We are elighte to confirm this new agreement with both Frontline an Seymour.160 Long term partnerships with publishers an istributors are central to our business moel an allow us to continue to rive efficiencies an eliver great service for publishers, retailers, an ultimately for millions of consumers across the UK."

160

160

Enquiries:

Smiths News PLC 160160160160160160160160160160160160160160160160160160160 160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160160 Via Buchanan

Jonathan Bunting, Chief Executive Officer

Paul Baker, Chief Financial Officer

www.smithsnews.co.uk

160

Buchanan

Richar Olworth / Jamie Hooper / Toto Berger 160 160 160 160 160 160 160 160 160 160 160 160 160 160 160 160 160 160 160020 7466 000

smithsnews@buchanan.uk.com

www.buchanan.uk.com

160

160

Person responsible for arranging release of this announcement:

Stuart Marriner

General Counsel Company Secretary

Smiths News plc

Rowan House

Cherry Orchar North

Kembrey Park

Swinon

SN2 8UH

email: cosec@smithsnews.co.uk

This information is provie by RNS, the news service of the Lonon Stock Exchange. RNS is approve by the Financial Conuct Authority to act as a Primary Information Provier in the Unite Kingom. Terms an conitions relating to the use an istribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP aress to confirm compliance with the terms an conitions, to analyse how you engage with the information containe in this communication, an to share such analysis on an anonymise basis with others as part of our commercial services. For further information about how RNS an the Lonon Stock Exchange use the personal ata you provie us, please see our Privacy Policy.160 END160160CNTFLFITIVLRLIF
Date   Source Headline
6th May 20267:00 amRNSInterim Results as at 28 February 2026
19th Mar 20267:00 amRNSContract Renewal with The Guardian
27th Feb 20263:00 pmRNSBlock listing Interim Review
23rd Feb 20267:00 amRNSStatement re Tuffnells Parcels Express Pension
10th Feb 20265:32 pmRNSDirector/PDMR Shareholding - Correction
3rd Feb 20262:18 pmRNSDirector/PDMR Shareholding
29th Jan 20262:25 pmRNSResult of Annual General Meeting
29th Jan 20267:00 amRNSTrading Statement
6th Jan 202611:48 amRNSHolding(s) in Company
16th Dec 20254:55 pmRNSNotice of AGM
12th Dec 20255:15 pmRNSDirector/PDMR Shareholding
9th Dec 20252:11 pmRNSDirector/PDMR Shareholding
3rd Dec 202512:08 pmRNSDirector/PDMR Shareholding
28th Nov 20257:00 amRNSDirector/PDMR Shareholding
14th Nov 202510:38 amRNSDirector/PDMR Shareholding
4th Nov 20257:00 amRNSPreliminary Results
6th Oct 20257:00 amRNSNotice of Results and CFO Transition
23rd Sep 20257:00 amRNSTrading Statement
1st Sep 20254:20 pmRNSBlock listing Interim Review
31st Jul 20257:00 amRNSAppointment of Chief Financial Officer
7th May 20257:00 amRNSHalf-year Report
28th Mar 20257:00 amRNSTrading Statement
4th Mar 20257:00 amRNSDirectorate Change
28th Feb 202511:27 amRNSBlock listing Interim Review
16th Jan 20251:50 pmRNSResult of AGM
16th Jan 20257:00 amRNSTrading Statement
7th Jan 20257:00 amRNSBoard Changes
13th Dec 20241:13 pmRNSNotice of AGM
12th Dec 20243:09 pmRNSHolding(s) in Company
10th Dec 20247:00 amRNSContract Renewal Reach PLC
29th Nov 20242:47 pmRNSDirector/PDMR Shareholding
29th Nov 20242:45 pmRNSDirector/PDMR Shareholding
29th Nov 20242:44 pmRNSDirector/PDMR Shareholding
29th Nov 20242:43 pmRNSDirector/PDMR Shareholding
29th Nov 20249:16 amRNSDirector/PDMR Shareholding
14th Nov 20243:23 pmRNSDirector/PDMR Shareholding
8th Nov 202411:47 amRNSHolding(s) in Company
6th Nov 20242:44 pmRNSHolding(s) in Company
6th Nov 202411:44 amRNSDirector/PDMR Shareholding
5th Nov 20247:00 amRNSFinal Results
18th Oct 20247:00 amRNSAppointment of Joint Corporate Broker
17th Oct 20249:37 amRNSNotice of Full Year Results
14th Oct 20249:28 amRNSHolding(s) in Company
2nd Oct 20247:00 amRNSPost Close Trading Statement
2nd Sep 20249:46 amRNSBlock listing Interim Review
2nd May 20247:00 amRNSRefinancing Agreement
2nd May 20247:00 amRNSHalf-year Report
18th Apr 20247:00 amRNSNotice of Results
1st Mar 20248:18 amRNSBlock listing Interim Review
31st Jan 202412:55 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.